HTEC stock forecast, quote, news & analysis

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Intuitive Surgical (NASDAQ:ISRG), Bristol-Myers Squibb Co (NYSE:BMY), Boston Scientific Corp (NYSE:BSX), Regeneron Pharmaceuticals (NASDAQ:REGN), Edwards Lifesciences Corp (NYSE:EW), IQVIA Holdings (NYSE:IQV), Align Technology (NASDAQ:ALGN), Illumina (NASDAQ:ILMN), Incyte Corp (NASDAQ:INCY).

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the ROBO Global® Healthcare Technology and Innovation Index. The fund will normally invest at least 80% of its total assets in securities of the index or in depositary receipts representing securities of the index. The index is designed to measure the performance of companies that have a portion of their business and revenue derived from the field of healthcare technology, and the potential to grow within this space through innovation and market adoption of such companies’ products and services. It is non-diversified.

The average market capitalization across the Robo Global® Hlthcare Tech & Innovt ETF ETF is 33.48B. The market cap for tickers in the group ranges from 348.67M to 220.19B. TMO holds the highest valuation in this group at 220.19B. The lowest valued company is AXGN at 348.67M.

The average weekly price growth across all stocks in the Robo Global® Hlthcare Tech & Innovt ETF ETF was -6%. For the same ETF, the average monthly price growth was -4%, and the average quarterly price growth was -0%. NTRA experienced the highest price growth at 9%, while DNA experienced the biggest fall at -25%.

The average weekly volume growth across all stocks in the Robo Global® Hlthcare Tech & Innovt ETF ETF was 46%. For the same stocks of the ETF, the average monthly volume growth was 98% and the average quarterly volume growth was 95%